ANAPTYSBIO, INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ANAPTYSBIO, INC has filed 716 SEC EDGAR filings since 06 Jul 2006

SEC filing history

Showing 551-575 of 709 matching filings.

Per page
25
Current page
23
424B5 File 333-222868

424B5

Filing date
26 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-222868

424B5

Filing date
24 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37985

FORM 8-K

Filing date
24 Sep 2018
Reporting date
24 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
19 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-37985

10-Q/A

Filing date
14 Sep 2018
Reporting date
30 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-37985

10-Q/A

Filing date
14 Sep 2018
Reporting date
31 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-37985

10-K/A

Filing date
14 Sep 2018
Reporting date
31 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
11 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Sep 2018
Reporting date
07 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Aug 2018
Reporting date
06 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 Aug 2018
Reporting date
06 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37985

8-K

Filing date
07 Aug 2018
Reporting date
07 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jul 2018
Reporting date
09 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37985

8-K

Filing date
12 Jun 2018
Reporting date
12 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jun 2018
Reporting date
08 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89797

JANUS HENDERSON GROUP PLC OWNS 10.0%-AMENDMENT

Filing date
11 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37985

8-K

Filing date
23 May 2018
Reporting date
18 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 May 2018
Reporting date
11 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 May 2018
Reporting date
11 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 May 2018
Reporting date
11 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89797

FRAZIER HEALTHCARE V, L.P. / ANAPTYSBIO, INC. -- SCHEDULE 13D/A - AMEND. NO. 2

Filing date
15 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-37985

10-Q filing

Filing date
08 May 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
8-K File 001-37985

8-K

Filing date
08 May 2018
Reporting date
08 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37985

DEFA14A

Filing date
26 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .